[ET Net News Agency, 27 August 2026] HANSOH PHARMA (03692) rose 15.3% to HK$36.6.
It hits an intra-day high of HK$36.62, hitting an 1-month high, breaking above the 250-D SMA of HK$35.517, and an intra-day low of HK$33.42. The total shares traded was 10.52 million, with a value of HK$370.17m. The active buy/sell ratio is 69:31, with net buying turnover of HK$124.78m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$3.08m, with volume weighted average price of HK$35.541. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$24.85m, with volume weighted average price of HK$35.338. The stock has risen a combined 17.8% over the past 3 consecutive trading days.
The Hang Seng Index now fell 95 points, or 0.4% to 25,557; the Hang Seng China Enterprises Index now fell 34 points, or 0.4% to 8,499.
Basic Information| Nominal | 36.600 | % Chg | +15.31% |
| High | 36.620 | Low | 33.420 |
| Shares Tr | 10.52m | Turnover | 370.17m |
| 10-D SMA | 32.986 | %H.V | 40.462 |
| 20-D SMA | 32.884 | VWAP | 35.190 |
| 50-D SMA | 32.094 | RSI14 | 65.828 |
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is 69:31, with net buying turnover of HK$124.78m, rising a combined 17.8% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 36.600 | +15.31 |
| SIHUAN PHARM (00460) | 0.760 | -6.75 |
| GRAND PHARMA (00512) | 5.335 | +0.66 |
| SBP GROUP (01177) | 5.705 | -0.52 |
| HENGRUI PHARMA (01276) | 46.600 | -0.26 |
| LIVZON PHARMA (01513) | 20.100 | -0.50 |
| LUYE PHARMA (02186) | 2.160 | -0.46 |
| FOSUN PHARMA (02196) | 16.350 | +0.18 |
| UNI HEALTH (02211) | 0.660 | -2.22 |
| CHINARES PHARMA (03320) | 4.640 | +1.20 |
(ed)
